Proton pump inhibitors modulate remodeling/fibrosis-related gene expression in patients with Eosinophilic esophagitis and inhibit TGF-β‒induced profibrotic responses in esophageal fibroblasts @jacionline.bsky.social @cincyresearch.bsky.social #RothenbergLab #Shoda